Tissue engineering: Growing new organs, and more
Research could lead to better ways to heal injuries and develop new drugs.
Research could lead to better ways to heal injuries and develop new drugs.
Jellyfish-inspired device that rapidly and efficiently captures cancer cells from blood samples could enable better patient monitoring.
New MIT study identifies adhesion molecules key to cancer’s spread through the body.
MIT finance researchers say a diversified ‘megafund’ of securities could help the industry deliver new products to consumers.
Drug-like molecule restores normal cell metabolism, preventing cancer cells from growing.
Particles that shut off cancer genes could also allow researchers to screen potential drug targets more rapidly.
Platinum compound may offer an alternative to cisplatin, a widely used chemotherapy agent.
Findings may help predict colon cancer risk for patients with inflammatory bowel disease.
New MIT study offers comprehensive look at chemical and genetic changes that occur as inflammation progresses to cancer.
Pared-down nucleic acid nanoparticle poses less risk of side effects, offers better targeting.
New MIT study shows that staggered delivery of cancer drugs is far more effective than administering them at the same time.
Tiny particles could manufacture cancer drugs at tumor sites.
Tiny particles designed to home in on cancer cells achieve tumor shrinkage at lower doses than traditional chemotherapy.
Killian Award recipient JoAnne Stubbe says some free radicals can be good for you.
Institutions, research teams, non-profit organizations join forces in novel approaches targeting pancreatic cancer, glioblastoma.